Colon Capsule will eventually come close to Gold Standard Colonoscopy
Granted, this is a field with a lot of upside potential, but 2017 seems like a very long time to wait. On the other hand, the PillCam seems like a small percentage of GIVN's revenue stream, so I think I'll hold for a while and see what the next ER brings.
What do you mean--PillCam small % of Given.It is close to 135-140 million$ out of 185-195mil.$ sales(Ph sales are close to 50mil.$--acquired co.). If you mean Colon 2 Capsule--that has not received FDA approval in USA. Given is saying it expects 450 mil.$ sales for Colon 2 in 2016.Do you trust the CEO Shamir?
I was referring to the the PillCam Colon 2, which contributed $1.8 million to Given’s total sales of $178 million in 2011. The stock will get a bump if Colon 2 is FDA-approved in the U.S, but it has a long way to go after being so badly beaten down. Shamir is only giving a projection--it's not written in stone. Right now, I'm kicking myself for not selling GIVN when I had a nice profit instead of a hefty loss.